Ohio Gov. Mike DeWine stopped by Cincinnati Children’s on Dec. 5 to announce a major boost for pediatric cancer research—a $1.48 million grant to power the ENGRAFT learning network. This collaborative effort brings together experts, families, and partners to transform outcomes for kids needing stem cell transplants, as part of a $5 million statewide investment in fighting childhood cancer.
Discover new research from Cincinnati Children’s revealing how pregnancy enhances antibody function, opening potential pathways for improved vaccines and therapies.
Discover how Cincinnati Children’s uses 3D imaging to improve precision and outcomes in pediatric physeal bar excision surgery.
The new Applied Gene and Cell Therapy Center will expand capacity for manufacturing viral vectors and cell-based products under Current Good Manufacturing Practice conditions, supporting complex trials in oncology, hematology and rare genetic disorders, with capabilities for large-scale bioreactor production and post-approval therapy manufacturing.
Breakthrough research at Cincinnati Children’s reveals new biological mechanisms behind muscle contractures, opening pathways for future prevention and treatment.
Cincinnati Children’s expands access to TMS for adolescents with depression, building on decades of pediatric research and delivering coordinated, evidence-based care.
Discover how Cincinnati Children’s CF WELL program is transforming care for children with cystic fibrosis—addressing educational and mental health needs alongside clinical advances.
Explore how Cincinnati Children’s neurologists are addressing social determinants of health to improve outcomes for patients with rare neuroimmune disorders.
Research from Cincinnati Children’s shows advanced neuroimaging can identify preterm infants at risk for developmental disorders, enabling earlier, targeted interventions.
User-defined virtual sensor beamforming pinpoints seizure onset zones beyond the temporal lobe, providing a solution for locating epilepsy sources other methods miss.